SCHEMBL2597869

SCHEMBL2597869

CCOC(=O)CCC1CCC(=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
TDP1 Q9NUW8 3/20 0.43
USP2 O75604 1/20 0.43
ALOX15 P16050 1/20 0.43
L3MBTL1 Q9Y468 4/20 0.41
KMT2A Q03164 2/20 0.40
CYP2D6 P10635 1/20 0.39
CYP1A2 P05177 1/20 0.39
KLK7 P49862 3/20 0.39
GAA P10253 2/20 0.38
MGAM O43451 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
ATM Q13315 1/20 0.38
SMYD3 Q9H7B4 1/20 0.37
HPGD P15428 1/20 0.37
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6792334 0.90 ALDH1A1 (0.44) ALDH1A1TDP1USP2ALOX15L3MBTL1
SCHEMBL26828383 0.90 ALDH1A1 (0.41) ALDH1A1TDP1USP2ALOX15L3MBTL1
SCHEMBL11004376 0.87 ALDH1A1 (0.52) ALDH1A1TDP1USP2ALOX15CYP1A2
SCHEMBL18623243 0.85 ALDH1A1 (0.50) ALDH1A1TDP1USP2ALOX15L3MBTL1
SCHEMBL9054489 0.82 TSHR (0.43) ALDH1A1TDP1L3MBTL1KMT2AKLK7
SCHEMBL9106913 0.82 ALDH1A1 (0.42) ALDH1A1TDP1USP2ALOX15L3MBTL1
SCHEMBL2257497 0.82 KMT2A (0.41) ALDH1A1TDP1KMT2ACYP2D6CYP1A2
SCHEMBL2648207 0.82 MEN1 (0.51) ALDH1A1TDP1USP2ALOX15L3MBTL1
SCHEMBL7886952 0.82 ALDH1A1 (0.49) ALDH1A1TDP1USP2ALOX15L3MBTL1
SCHEMBL6421923 0.81 TDP1 (0.41) ALDH1A1TDP1USP2ALOX15L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110357813-A A kind of new indole amine 2,3- dioxygenase inhibitor and its preparation method and application 信达生物制药(苏州)有限公司 2019-10-22 CN disclosed
EP-2571351-B1 DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES MERCK SHARP & DOHME (US) 2016-09-14 EP disclosed
US-8623846-B2 Diazeniumdiolate cyclohexyl derivatives MERCK SHARP & DOHME CORP. (US) 2014-01-07 US disclosed
WO-2013157792-A1 BICYCLIC HETEROARYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME HANMI PHARM. CO., LTD. (KR) 2013-10-24 WO disclosed
WO-2013157792-A1 BICYCLIC HETEROARYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME HANMI PHARM. CO., LTD. (KR) 2013-10-24 WO disclosed
EP-2571351-A1 DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES Merck Sharp & Dohme Corp. (US) 2013-03-27 EP disclosed
US-20130059823-A1 Diazeniumdiolate Cyclohexyl Derivatives MERCK SHARP & DOHME LLC 2013-03-07 US disclosed
WO-2011146371-A1 DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2011-11-24 WO disclosed
US-7786305-B2 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity MERCK SHARP & DOHME CORP. (US) 2010-08-31 US disclosed
EP-1501507-B1 TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO INC (US) 2008-05-28 EP disclosed
US-20050107422-A1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity MERCK SHARP & DOHME LLC 2005-05-19 US disclosed
US-20050101628-A1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity MERCK SHARP & DOHME LLC 2005-05-12 US disclosed
EP-1501507-A2 TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2005-02-02 EP disclosed
US-6812234-B2 CCR-2; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES MERCK & CO., INC. 2004-11-02 US disclosed
US-20040167156-A1 TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK SHARP & DOHME LLC 2004-08-26 US disclosed
WO-2003092586-A2 TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2003-11-13 WO disclosed
US-4222944-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIRHEUMATIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1980-09-16 US disclosed
US-4192809-A USED A ANTIINFLAMMATORY, ANALGESIC, AND ANTIRHEUMATIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1980-03-11 US disclosed
US-4097497-A ANTIINFLAMMATORY, ANALGESICS, ANTIRHEUMATIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1978-06-27 US disclosed
US-4022805-A ANTIINFLAMMATORY, ANALGESIC, ANTIRHEUMATIC HOFFMANN-LA ROCHE INC. (US) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059823-A1 Diazeniumdiolate Cyclohexyl Derivatives OR10J3, CBR3, CBR1 ALDH1A1 1368/4885TDP1 2598/4885USP2 2367/4885
US-20050107422-A1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity CCR1, CCR9, CCR2 ALDH1A1 2141/4885TDP1 3122/4885USP2 2962/4885
US-20050101628-A1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity CCR2, CCR9, CCR1 ALDH1A1 2240/4885TDP1 3609/4885USP2 3130/4885
US-20040167156-A1 TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY CCR1, CCRL2, CCR5 ALDH1A1 1905/4885TDP1 4110/4885USP2 3414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.